Langer R. & Vacanti JPTissue engineering. Science1993; 260: 920-6.
2.
Slivka SR, Landeen LK, Zeigler F., Zimber MP & Bartel RLCharacterization, barrier function, and drug metabolism of an in vitro skin model. Journal of InvestigativeDermatology1993; 100: 40-6.
3.
Sherard Braa S. & Triglia D.Predicting ocular irritation using three-dimensional human fibroblast cultures. Cosmetics & Toiletries1991; 106: 55-8.
4.
Triglia D., Kidd I., De Wever B. & Rooman R.Interlaboratory validation study of the Advanced Tissue Sciences' Skin2™ dermal model and MTT cytotoxicity assay kits. AATEX1992; 1: 142-7.
5.
Slivka S., Stevens-Burns D., Naughton G. & Bartel R.A novel method for colorimetric assessment of collagen matrix deposition in a three-dimensional dermal culture system. In Vitro Cellular and Developmental Biology1991; 27: 159A.
6.
Contard P., Bartel RL, Jacobs II L., Perlish JS, MacDonald II ED, Handler L., Cone D. & Fleischmajer R.Culturing keratinocytes and fibroblasts in a three-dimensional mesh results in epidermal differentiation and formation of a basal lamina-anchoring zone . Journal of Investigative Dermatology1993 ; 100: 35-9.
7.
Slivka SR & Zeigler F.Use of an in vitro skin model for determining epidermal and dermal contributions to irritant responses. Journal of Toxicology - Cutaneous & Ocular Toxicology1993; 12: 49-57.
8.
Pirovano R., Zaninelli P., Noben J., Logemann P., Southee J., Joller P. & Coquette A.A European interlaboratory evaluation study of an in vitro ocular irritation model (Skin2™ Model ZK1100) using 15 chemicals and three shampoos. ATLA1993; 21: 81-8.
9.
Osborne R., Perkins MA, Roberts DA & Bruner LHDevelopment of an in vitro assay for ocular irritancy assessments on aqueous incompatible substances (abstract). The Toxicologist1992; 12: 296.
10.
Slivka SR & Bartel RLRapid estimation of collagen in a dermal model (letter to the editor). In Vitro Cellular DevelopmentalBiology1992; 28A: 690-2.
11.
Contard P., Jacobs II L., Perlish JS & Fleischmajer R.Collagen fibrillogenesis in a three-dimensional fibroblast cell culture system. Cellular Tissue Research (in press).
12.
Zeigler, FC , Landeen, L.Naughton, GK & Slivka, SRA tissue-engineered, three-dimensional human dermis to study extracellular matrix formation in wound healing. Journal of Toxicology - Cutaneous & Ocular Toxicology (in press).
13.
Fleischmajer R., MacDonald II ED, Contard P. & Perlish JSImmunochemistry of a keratinocytefibroblast co-culture model for reconstruction of human skin . Journal of Histochemistry and Cytochemistry1993; 41: 1359-66.
14.
Fleischmajer R., Contard P., Schwartz E., MacDonald II ED & Sakai LYElastin-associated microfibrils (10 nm) in a three-dimensional fibroblast culture. Journal of Investigative Dermatology1991; 97: 638-43.
15.
Yang JJ & Krueger AJEvaluation of two commercial human skin cultures for in vitro percutaneous absorption. In Vitro Toxicology1992; 5: 211-7.
16.
Slivka SRTestosterone metabolism in an in vitro skin model. Cell Biology andToxicology1992; 8: 267-76.
17.
Vanden Bossche H., Willemsens G., Schreuders H. et al. Use of human skin models in the study of retinoic acid metabolism and lipids synthesis: Effects of liarozole. In Human Cells in Vitro Pharmacotoxicology - Present Status within Europe eds V. Rogiers, W. Sonck, E. Shephard & A. Vercruyze. pp. 61-76. Brussels , VUB Press, 1993.
18.
Draize JHMethods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. Journal of Pharmaceutical and Experimental Therapy1944; 82: 377.
19.
Draize JHDermal toxicity. Food, Drug, and CosmeticLaw Journal1955; 10: 722-732.
20.
US Consumer Product Safety Commission (CPSC) method for testing primary dermal irritation (under the "Federal Hazardous Substance Act") 16CFR, 1500.3 and 1500.41.
21.
Triglia D., Sherard Braa S., Donnelly T., Kidd I. & Naughton GKA three-dimensional human dermal model substrate for in vitro toxicological studies. In: Goldberg AM (ed.). Alternative Methods in Toxicology, Vol. 8. New York: MaryAnn Liebert, Inc.1991: 351-362.
22.
Contard P., Jacobs II L., Perlish JS & Fleischmajer R.Collagen fibrillogenesis in a three-dimensional fibroblast cell culture system. Cell and Tissue Research (In press).
23.
Naughton BA , Sibanda B., Azar L. & San Román J.Differential effects of drugs upon hematopoiesis can be assessed in long-term bone marrow cultures established on nylon screens. P.S.E.B.M.1992 ; 199: 481-90.
24.
Tjota A., Rossi TM & Naughton BAStromal cells derived from spleen or bone marrow support the proliferation of rat natural killer cells in long-term culture. P.S.E.B.M.1992; 200: 431-41.
25.
Landeen LK, Zeigler FC, Halberstadt C., Cohen R. & Slivka SRCharacterization of human dermal replacement. Wounds1992; 4: 167-75.
26.
Hansbrough JF, Doré C. & Hansbrough WBClinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. Journal of Burn Care and Rehabilitation1992; 13: 519-29.
27.
Freed LE, Marquis JC, Nohris A., Mikos AG, Ammanual J. & Langer R.Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. Journal of Biomedical Materials Research1993; 27: 11-23.
28.
Donnelly TA , Destandau P., Allen R., Edwards SM & Rheins LAAn in vitro skin model for the study of collagen matrix deposition by fibroblasts. Abstracts. Journal of InvestigativeDermatology1993; 100: 551.
29.
Edwards SM, Donnelly TA, Sayre RA & Rheins LAQuantitative in vitro assessment of phototoxicity using a human skin model, Skin2™. Journal of Photodermatology, Photoimmunology Photomedicine1992 (in press).